Ray Therapeutics, Inc.

Our CEO Paul Bresge will be moderating a panel at Ophthalmology Innovation Source Summit 2024 on November 22, 4.05-4.40 pm PT. 🧬🧬 Investor Strategy: Understanding Your Investors And Your Investment Strategies Panelists: Anna H. Chen, PhD, Principal - Frazier Life Sciences Jeffrey Friedman, MD, PhD, Managing Partner - Friedman BioVenture Joe Markson, PhD, Principal - Novo Holdings Zach Scheiner, PhD, Principal - RA Capital Management Co-Moderated By: Paul Bresge, CEO - Ray Therapeutics, Inc. Jason Jun, Managing Director, Healthcare Investment Banking - Citi Our Chief Medical & Scientific Officer Peter Francis, MD PhD will be giving a company presentation in the Cell & Gene Therapy Showcase at 4.40-5.30 pm ET. More info here: 👇👇 https://lnkd.in/eSUHtXDp

Our CEO Paul Bresge was on the #BioFuture panel “Emerging Technologies and Approaches in Cell and Gene Therapy,” last week in New York. 🧬🧬 The panel was moderated by Lei Lei Wu at Endpoints News. As the field of cell and gene therapy advances, the panel discussed how emerging technologies are overcoming current limitations, improving precision, and accelerating the path from research to clinical application to pave the way for more effective and accessible cell and gene therapies. Panelists: * Paul Bresge, CEO, Ray Therapeutics, Inc. * Parastoo Khoshakhlagh, Ph.D., CEO & Co-Founder, GC Therapeutics * Kate Rochlin, PhD, COO, IN8bio Thanks Demy-Colton for inviting us! #biotech #genetherapy #optogenetics

📣 Speaker Announcement! We’re excited to announce that Paul Bresge, CEO at Ray Therapeutics, Inc., will be speaking at Biotech Showcase 2025! Paul has been a leader in the cell and gene therapy biotech space for over a decade, join him at the session ‘Cell & Gene Therapy: Moving Beyond Discovery and Into the Patient’. Unlock the ultimate potential of cell and gene therapy to revolutionize patient care. Find out more about what is in store at Biotech Showcase >> https://lnkd.in/euTRssxz #BiotechShowcase #CellandGeneTherapy #SanFrancisco Demy-Colton

Thanks Cell & Gene and Erin Harris for speaking with our CEO Paul Bresge. 🧬🧬 It was a pleasure joining #CellAndGenePodcast to talk about #optogenetics and how our approach differs from other gene therapies on the market developed to restore vision in diseases like #retinitispigmentosa. Watch the YouTube video interview here: https://lnkd.in/exq6NR6Y Listen to the podcast: https://lnkd.in/eFmdXRCF

Episode 86 of Cell & Gene: The Podcast is available! Ray Therapeutics, Inc.' Co-Founder and CEO, Paul Bresge joins me to discuss all things vision-restorative therapeutics. We talk through #optogenetics-based #genetherapies for #vision restoration and how the company’s optogenetics approach differs from other gene therapies on the market. Subscribe wherever you podcast to hear our informative discussion. #podcast #cellandgenetherapy #cgt #eyecare #biotech https://lnkd.in/eN3NBxdu

We’re excited to welcome Christopher Whitmore as CFO. Mr. Whitmore is a highly accomplished executive who brings over 20 years of strategic finance, accounting, and operational expertise. “Chris brings extensive experience leading high-performing teams in the private and public sectors. He has a proven track record of success in our industry, and we are thrilled to welcome him to the team as we enter a new and exciting stage of development,” said Paul Bresge, CEO, Ray Therapeutics. “Chris will be an invaluable asset to our leadership team as we advance our clinical pipeline of optogenetic therapies to restore vision in patients with degenerative retinal diseases.” Read the release: https://lnkd.in/e_jgFeNH

Our Chief Development Officer Jenny Holt moderated a fantastic session today at LSX USA Congress in Boston on “Fast-Tracking Biotech Growth.” Thanks to all the panelists who participated and great discussion. #LSXCongress

Excited to share that our Chief Development Officer Jenny Holt will be moderating this panel today at the LSX USA Congress in Boston: What is Required to Scale? Fast-tracking Biotech Growth. Hope to see you all there! Sharing the agenda here: https://lnkd.in/eu7VgYU7

Come join the Ray Therapeutics Team! https://lnkd.in/gVszaPsC

Our Chief Medical Officer Peter Francis, MD PhD will be speaking at the 5th Gene Therapy for Ophthalmic Disorders Summit in September 10-12 in Boston, MA. There will be: Expert Speakers from across R&D, preclinical and clinical development Interactive workshops on crucial topics spanning delivery, animal models, endpoint selection and regulatory challenges Days of cutting edge content from AAVs and innovating vectors to confirming suitable clinical endpoints For more information, visit: https://ter.li/xs2c2a  Looking forward to seeing everyone there!